-4.5 C
Ottawa
Wednesday, April 2, 2025

Cancer-treatment developer CG Oncology files for IPO

Date:

Bladder-cancer treatment developer CG Oncology filed for an initial public offering with the Securities and Exchange Commission.

Thank you for reading this post, don't forget to subscribe!

The Irvine, Calif.-based biopharmaceutical company is developing a potential therapeutic for bladder-cancer patients who are unresponsive to immunotherapy Bacillus Calmette-Guerin treatment.

CG Oncology did not say how many shares it planned to offer or give an estimated price range. The company plans to use proceeds primarily for supporting operations.

The company has applied to list its shares on the Nasdaq Global Market under the ticker CGON.

Morgan Stanley, Goldman Sachs & Co., Cantor and Lifesci Capital are acting as the underwriters of the offering.

know more

Popular

More like this
Related

All 118(!) major trophies won by players who have left Spurs since 2008…

You know what’s funny? That Spurs never win anything. It is a never-ending seam of rich comedy content. Whether that’s from brands as diverse as Dulux paint and Domino’s pizza raking in the guffaws and sweet, sweet likes on the socials, or us taking the piss , it’s absolutely never not funny. But you know

School cancelled in N.B., P.E.I. on Monday due to freezing rain warning across Atlantic Canada

PEIAll Public Schools Branch and French-language board schools on...

Judge calls out WestJet’s attempt to muzzle passenger in dispute negotiations

Andrew Douglas says he was just fighting for compensation...

Who’s considered ‘middle class’ in Canada? And who’s left behind?

The so-called middle class is the prized demographic for Canada's...